Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism-Reference-Cited by-同舟云学术

Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism

Published:2015-12 Issue:1 Volume:12 Page:
ISSN:1743-7075
Container-title:Nutrition & Metabolism
language:en
Short-container-title:Nutr Metab (Lond)

Author:

Veleba Jiri,Kopecky Jan,Janovska Petra,Kuda Ondrej,Horakova Olga,Malinska Hana,Kazdova Ludmila,Oliyarnyk Olena,Skop Vojtech,Trnovska Jaroslava,Hajek Milan,Skoch Antonin,Flachs Pavel,Bardova Kristina,Rossmeisl Martin,Olza Josune,de Castro Gabriela Salim,Calder Philip C.,Gardlo Alzbeta,Fiserova Eva,Jensen Jørgen,Bryhn Morten,Kopecky Jan,Pelikanova Terezie

Funder

Ministry of Health of the Czech Republic

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s12986-015-0047-9.pdf

Reference39 articles.

1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015;58:429–42.

2. American DA. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37 Suppl 1:S14–80.

3. Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD, Kim KR, et al. Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem. 2014;289:23246–55.